Hanns-DieterGruemer,1W. Greg Miller,1Vernon M. Chinchilli,2Robert T. Leshner,3Carol R. Hassler,4Peter A. Blasco,1Walter E. Nance,5 and Barbara M. Goldsmith6
only did values for serum CK activities disagree from one laboratoryto another, there was also considerable disagreement among laboratories in the assigned probability value for carrier status. Several other studies, attempts to define criteria for a positive CK result, have been hampered by small numbers of samples (usually fewer than 100), which fail adequately to define the markedly skewed upper reference limit. Cutoff values between healthy and carrier populations have been assigned by applying gaussian statistical analysis, either directly to the data or to a logarithmic transformation of it. Logarithmic and other transformations will not "normalize" distributions that are as markedly skewed towards higher values as are results for serum CK activity in a healthy population, where data from approximately 400 observations are necessary to definethe skewed tail region adequately (3). One large seriesin the literature (4), with which many smaller studies are in harmony, confirms the markedly skewed distribution of CK results in control populations. The distribution of CK results for carriers of DMD in this and many previous studies overlaps markedly with that for controls, making CK assay rather unsuitable as a laboratory test for carrier status.
Because the use of CK for carrier detection in DM1) is clouded by inadequate reference populations and cutoff values, we undertook this prospective study of the relationship between the distribution of CK values in control individuals and carriers of DMD. More broadly, our objective was to apply quantitative statistical methods to understand the problems involved when a medical diagnosis relies on a test for which the results are non-gaussian and distributions overlap between non-diseased and diseased populations.
Materials and Methods
Serum was sampled from the ambulatory control group after a medical history was taken and a physical exanunation performed on each individual to assure that she was in good health. The samples were collected during a four-year, period from 580 females, ages one to 77 years,none of them known to be pregnant. When an individual was tested on more than one occasion, we used only the first recorded observation in this study.
Serum specimens
were also obtained from 28 obligate carriers and 43 mothers of simplex casesof DM1) during this same four-year period.
Specimens were allowed to clot, centrifugedwithin a few hours of sampling, and the supernatant serum was separated and stored refrigerated. Control specimens were never stored longer than about 48 h; each patient's specimen w usually analyzed the same day it was collected. Hemoly serum specimens were not used in this study, to avoid th problem of contamination with adenylate kinase (EC 2.7.4.3)from erythroeytes.
We measured creatine kinase activity by use ofa modified oupled Rosalki reaction (5) in a Model KA-150 kinetic mzyme analyzer (Perkin-Elmer Corp., Norwalk, CT), with reagents from Perkin-Elmer. This instrument provides a 6-mn preincubation of serum with buffer, co-factors, and 3.ithiothreitol, followed by addition of substrate and meaturement of the rate of reaction at 37 #{176}C. During the early part of this study-i.e., prior to March 1979-we measured OK activity in a continuous-flow analysis system (srviAc; Fechnicon Instruments Corp., Tarrytown, NY) by a modifiration of the method of Siegel and Cohen (6), using secondery standards for calibration to produce a result equivalent to that produced by the kinetic analyzer (7) .
After the data collection for this study was terminated, we replaced the Perkin-Elmer instrument with a Cobas-Bio rentrifugal analyzer(Roche Analytical Instruments, NutLey,NJ), updated the reagent formulation to conform to the recommendations of the Scandinavian Committee on Enrymes, and re-analyzed some of the specimens (8). Regrestion analysis by use of the Deming approach (9) between the Cobas method (y) and the Perkin-Elmer method (x) for 81 patients' specimens (activity range, 6-1075 UIL) gave y = l.30x + 4. We then multiplied all results in this study by the regression coefficient (1.30) before statistical analysis. The negligible intercept error was ignored. This adjustment permitted us to directly apply the reference intervals deterruined earlier in the study to results obtained with the ptimized and widely used recommended method of the Scandinavian Committee on Enzymes. Figure 1 shows the population density and the correlation rf CK activities with age in 580 females. The median for serum CK activities of various age groups decreases during the first two decades of life, with no significant changes thereafter. Because the number of individuals in each age group is small, one or two extreme values may substantially alter the estimate of the 97.5th percentile value. The change in CK activity with age combined with a skewed distribuLionand substantial overlap between populations make it difficult to interpret CK results for carrier detection in children. The virtually identical medians for the CK activities in the variousadult age groups and the large data base (1) where X represents the CK activity, P(XID) denotes the probability of X in the presence of carrier state and P(XID) the probability of X in the absence of carrier state. and specificities may be calculated from the curve; on the right-hand side of Figure 2 as detailedin th
Results
P(DIX) = p L(X)/[(1 -p) + pL(X)I(2)
Appendix.
The long-term stability of the CK results for the contro group is shown in Figure 5 , a plot of the medians 01 sequential groups of 40 individual results. We considei these data to be evidence that the population and tht 
Discussion
It is generally agreed that the distribution of serum CE activities is skewed towards high values (4, 10-13, 17-18) Such anomalies require a larger population size than it available to many laboratories before the upper limit to tIn normal reference interval can be estimated, and so the lo transformation is commonly used in an attempt to "norma1 ize" the data to fit a gaussian distribution. Table 1 , be just within the normal reference interval. However, the corresponding likelihood ratio indicates that she has a 1.8-fold likelihood of being a carrier as compared with a woman selected at random (Figure 4) . If one wants to test for the reliability of the ratio of 1.8 with 95% confidence, then 95 times out of 100 the ratio will be between 1.0 and 2.7. Such wide confidence intervals minimize the information value obtained from CK measurements. Even if the simplex and obligate carriers However, likelihood ratios become increasingly unreliable, for the purpose of genetic counseling, as the serum CK activities decrease into the normal rapge, because the large population overlap increases the possibility of misinformation on carrier status in individual cases, regardless of whether the test is used by itself or in combination with others.
The misinformation may even be magnified if the concepts of sensitivity (positivity of a test in disease) and specificity (negativity of a test in health) are used (13, 14) , both of which require by definition a common cutoff value. Sensitivity and specificity have a seesaw relationship when the distribution curves of normality and abnormality overlap. For CK activities, the change in specificity above 120 UI L is relatively small as compared to the change in sensitivity ( Figure 6 ). It is at high specificity (values exceeding 120 UIL) that the serum CK measurement eventually becomes useful for confirming carrier status. Because of the high incidence of the disease in the population seeking genetic counseling, the predictive value of a result exceeding120 U/ L for the mothers of simplex cases and daughters of obligate and possible carriers is about 80%. As CK cutoff values increase above 120 U/L (likelihood ratio of 1.0), the predictive value increases also. For instance, at a carrier prevalence of 0.5 (50%) and a CK cutoff value of 180 UIL, the predictive value of a positive test is 88%. Calculation of the combined probability from the likelihood ratio at 180 UIL is lower, namely 64%. The difference in value between the two methods is explicable: likelihood ratios reflect a continuum of results, but the predictive-value approach from test sensitivities and specificities dichotomizes information into values below anct above the cutoff value. The latter is applicable to any result that exceeds the cutoff point. Thus, when applied to a CK result near the cutoff point, the predictive value overstates the combined probability, while the likelihood ratio yields a more nearly accurate result. The value of either method in estimating the probability of DMD carrier status from CK results is limited by the substantial overlap between healthy and carrier populations, which greatly contributes to the broadness of the confidence interval for the likelihood ratio and the predictive value.
This analysis illustrates that the CK test is of marginal value in delineating carrier status in DMD unless the results exceed those for the healthy population interval, a Sensitivitieswerecalculated from data on the populationof 28 obligate carriers, the specificitiesfrom data on the 379 normalwomen.The predictivevalue (PV) was estimated from these data for daughters of obligate carriers, assuming prevalenceof .5.The 95% confidencelimits were calculatedfor predictivevalues (%PV (0.5)1of 83,88, and 91%, resultingin ranges of 75 to 92%, 76to97%,and 75 to 99%, respectively.The dOt ted line demonstrates perfect ROC (2, for comparison criterionmet by only a small proportion of carriers. Some authors (10, 11, 15) have attempted to determine the mutation rate for DMD on the basis of CK activity determinations in obligate carriers and mothers of sporadic cases. The assumption underlying this approach is that a single cutoff point can be used to differentiate carriers from non-carriers. Figure 2 clearly demonstrates that such cannot be the case, owing to the extensive overlap of the distribution curves of the normal female population and the obligate-carrier population. The lack of a significant difference between the CK activities of obligate carriers and mothers of simplex cases indicates that CK activity measurements will not distinguish these two populations. We cannot confirm or reject Haldane's hypothesis-that a third of all afflicted offspring with a genetically lethal disease are the result of a spontaneous mutation-as applied to muscular dystrophy on the basis of total CK activity measurements.
We are indebted to Dr. Daniel B. Drachman, Johns Hopkins University Schoolof Medicine, and Dr. ThaddeusKelly, University of Virginia Schoolof Medicine,for providinguswith bloodsamples from mothersof patients with Duchennedystrophy. This investigation was supported in part by the Muscular DystrophyAssociation, Let D and denote the diseased and non-diseased states, respectively, and let X = (X1, X2,. . ., X) denote a vector of k different diagnostic variables. The likelihood ratio is defined as the ratio of the conditional probability of X given D to the conditional probability of X given D, i.e.,
L(X) = P(XID)IP(XID).
L(X) is important in the determination of the disease state for an individual with a particular realization of X. L(X) is always a positive number and if it is much larger than 1, then the individual is more likely to be diseased. If L(X) is near to zero, then the individual is more likely to be non- 3ensitivity represents the proportion of diseased patients ivith a positive test result, and specificity represents the roportion of healthy individuals with a negative result. 3ensitivity indicates how "sensitive" the diagnostic test is to the diseased state, while specificity indicates how "specific" the diagnostic test is to the disease of interest and not the iealthy state or some other disease. if p is the prior #{231}robability of disease, then the combined risk (posterior probability or predictive value) is Suppose that the results of a diagnostic test can be summarized by the following two-by-two 
